Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Schlager

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|July 21, 2019
Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature reviewLukas Schlager, Michaela Loiskandl, Daniel Aletaha, et al.
International Journal of Surgery Case Reports|August 21, 2021
Bridging intestinal failure with Teduglutide - A case reportLukas Schlager, Anton Stift, Johanna Gartner, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 6, 2021
Teduglutide in short bowel syndrome patients: A way back to normal life?Felix Harpain, Lukas Schlager, Elisabeth Hütterer, et al.
International Journal of Surgery (London, England)|October 6, 2023
The predictive value of comorbidities on postoperative complication rates and overall survival in left-sided oncological colorectal resections: a multicentre cohort studyLukas Schlager, Matthias Monschein, Jessica Schüller, et al.
Wiener Klinische Wochenschrift|August 2, 2024
Does surgeon or hospital volume influence outcome in dedicated colorectal units?-A Viennese perspectiveGabor J Schuld, Lukas Schlager, Matthias Monschein, et al.
Annals of Surgical Oncology|February 9, 2023
Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center ExperienceFelix Harpain, Christopher Dawoud, Kerstin Wimmer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|July 21, 2019
Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature reviewLukas Schlager, Michaela Loiskandl, Daniel Aletaha, et al.
International Journal of Surgery Case Reports|August 21, 2021
Bridging intestinal failure with Teduglutide - A case reportLukas Schlager, Anton Stift, Johanna Gartner, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 6, 2021
Teduglutide in short bowel syndrome patients: A way back to normal life?Felix Harpain, Lukas Schlager, Elisabeth Hütterer, et al.
International Journal of Surgery (London, England)|October 6, 2023
The predictive value of comorbidities on postoperative complication rates and overall survival in left-sided oncological colorectal resections: a multicentre cohort studyLukas Schlager, Matthias Monschein, Jessica Schüller, et al.
Wiener Klinische Wochenschrift|August 2, 2024
Does surgeon or hospital volume influence outcome in dedicated colorectal units?-A Viennese perspectiveGabor J Schuld, Lukas Schlager, Matthias Monschein, et al.
Annals of Surgical Oncology|February 9, 2023
Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center ExperienceFelix Harpain, Christopher Dawoud, Kerstin Wimmer, et al.
Pageof 1